Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the ability of two peripheral and non invasive devices to detect hypoxic events during one-lung ventilation and during the early postoperative period. One device measures regional cerebral oxygenation and the other muscular oxygenation. These two devices are compared to non invasive arterial saturation (SpO2), which is the gold standard.


Clinical Trial Description

Lung surgery is often complicated by hypoxic evants :

- during one-lung ventilation which leads to changes about ratio in ventilated and perfused lung areas. This blood flow redistribution promotes shunt with a decreased arterial oxygenation and possible hypoxemia.

- during the postoperative period.

Common measure of arterial saturation through SpO2 may miss a great number of hypoxic events with regional impact because a significant decrease in SpO2 occurs for an arterial pressure in oxygen below 60 mmHg. Currently, cerebral and somatic saturation can be monitored non-invasively and continuously via optical sensors applied to the right and left forehead and to the thenar eminence. These devices may help clinicians in the detection of such hypoxemic events. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01255033
Study type Observational
Source Hopital Foch
Contact
Status Completed
Phase N/A
Start date November 2010
Completion date June 2011

See also
  Status Clinical Trial Phase
Completed NCT00925444 - Staple-line Reinforcement for Prevention of Pulmonary Air Leakage Phase 4
Completed NCT05126524 - Loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery
Recruiting NCT05600569 - Registry of the Spanish Society of Thoracic Surgery
Completed NCT03418090 - Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant Phase 3
Completed NCT03417687 - Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection Phase 3
Completed NCT02376218 - Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial. N/A